Quality in clinical development is a matter of operational resilience as much as regulatory mandate. This role serves as a GCPAuditorwithin our Research & Development Quality audit program, responsible for executing the global audit plan to ensure the accuracy of clinical trial data and compliance with legal and corporate standards. By conducting audits of our clinical investigator sites, external vendors, and internal trial management processes, you identify the findings and non-compliance trends that could impact the integrity of our clinical research. We are looking for an experienced auditor who can navigate complex clinical environments and work collaboratively with stakeholders to develop corrective actions that ensure long-term systemic stability.

Main Responsibilities

• Audit Execution:Conduct assigned external audits of clinical investigator sites, Contract Research Organizations (CROs), E-System providers, and Institutional Review Boards (IRBs/ECs)

• Reporting & Risk Categorization:Develop and issue comprehensive Audit Reports, categorizing findings by risk level and providing recommendations for corrective and preventive actions (CAPA) related to trial conduct and data integrity.

• Trend Analysis:Identify non-compliance trends and systematic risks within the Clinical (GCP) discipline, communicating these findings to line management and clinical functional leads to ensure trial robustness.

• Continuous Improvement:Support initiatives to improve standard operating procedures (SOPs) for audit conduct and partner with stakeholders to develop risk-based, compliant solutions for clinical trial management and monitoring.

• Regulatory Knowledge:Maintain up-to-date knowledge of global GCP regulations (ICH E6) and industry trends, identifying new requirements to ensure a high level of quality is maintained across all clinical development programs.

Position Qualifications & Experience

• Academic Background:BS degree in a relevant biological science, science, or related discipline

• Professional Experience:3+ years ofQuality Assurance experience within a GCP-regulated environment, demonstrating a strong understanding of clinical trial phases, monitoring, and regulatory frameworks.3+ years ofInspectionexperience withChina’sNational Medical Products Administration (NMPA; formerly CFDA)demonstrating a strong understanding of local inspection readinessand management within a GCP-regulated environment

• Audit& InspectionExpertise:Experience in clinical audit and inspection management, with a clear understanding of the requirements for quality assurance in the clinical research discipline

• Communication Skills:Excellent interpersonal and negotiation skills, with the ability to work effectively with multinational clinical teams, investigators, and external CROs. Professional fluency in Mandarin Chinese (written and spoken) is required to effectively manage communications and negotiations with key Asia-Pacific (APAC) stakeholders and partners.

• Working Knowledge of:ICH E6 (R3) Guideline, 21 CFR Part11 –ElectronicRecords; Electronic Signatures, 21 CFR Part50–Protection of Human Subjects (Informed Consent), 21 CFR Part312 –Investigational New Drug Application, 21 CFR Part812 –Investigational Device Exemptions, Clinical Trials Regulation (CTR) (EU) No 536/2014, Directive 2001/20/EC (Clinical Trial Directive), Directive 2005/28/EC (GCP Directive), Directive 2001/83/EC (Annex I)

• Organizational Agility:Strong analytical and problem-solving skills, with the ability to work with limited supervision and manage a schedule that includes up to 50% travel